Bonaca, Marc P <br/><br/>
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Jan 2011 
 - 203-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.110.213512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--blood<br/>Aged<br/>Angina, Unstable--blood<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Chi-Square Distribution<br/>Europe<br/>Female<br/>Growth Differentiation Factor 15--blood<br/>Heart Failure--blood<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Natriuretic Peptide, Brain--blood<br/>Patient Discharge<br/>Proportional Hazards Models<br/>Recurrence<br/>Risk Assessment<br/>Risk Factors<br/>Stroke--blood<br/>Time Factors<br/>Treatment Outcome<br/>United States